Innovation
1 patent family (1 granted) — focus: Human necessities; filing pace slowing. Cited 6 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Social engagement
Social engagement: 6.7K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
1 investor on record; lead investors include TVM Capital Healthcare.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 100% |
Recent activity
29 Jun 2026
Product launch
DEBRIX® + Microlyte® + Compression Therapy
25 Jun 2026
Event
EWMA 2026 after movie
18 Jun 2026
Event
Academy of the German Society for Vascular Surgery and Vascular Medicine (DGG) Event